AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2011
Jun 22, 2011
3174_iss_2011-06-22_33f3c632-c841-43b9-9dc6-3f0bf6d8cc67.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Östersjöstiftelsen
Instrument
| Instrument | Aktie SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | 0 |
| Voting rights | 0 |
| Transaction | |
| Reason for major shareholding notification Share loan | |
| Date | 22/06/2011 |
| Limit for number of shares | 25 % |
| Limit for number of votes | 25 % |
| After the transaction | |
| Quantity | |
| Shares | 2,274,179 |
| Directly held voting rights | 2,274,179 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 25 % |
| Directly held voting rights | 25 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, |
||
| first paragraph, line 3 - Physically settled - Cash settled |
||
| Total |
Published
22/06/2011 08:04
Contact
Name Kimmo Niva
Phone 08-70000854 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13